Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

0.5165
+0.04369.22%
Volume:2.95M
Turnover:1.50M
Market Cap:122.72M
PE:-1.38
High:0.5250
Open:0.4790
Low:0.4680
Close:0.4729
Loading ...

Sangamo Therapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
14 May

Truist Financial Reaffirms Their Buy Rating on Sangamo Biosciences (SGMO)

TIPRANKS
·
14 May

Top Premarket Decliners

MT Newswires Live
·
13 May

Sangamo Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

BRIEF-Sangamo Therapeutics Q1 EPS USD -0.14 Vs. IBES Estimate USD -0.13

Reuters
·
13 May

Sangamo Therapeutics Reports Q1 2025 Net Loss of $30.6 Million, Down from $49.1 Million in 2024; EPS Improves to $0.14 Loss from $0.27

Reuters
·
13 May

Sangamo Therapeutics Q1 Operating Expenses USD 36.1 Million

THOMSON REUTERS
·
13 May

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering

THOMSON REUTERS
·
13 May

Sangamo Therapeutics Launches $23 Million Share Offering with Warrants Priced at $0.50 Each

Reuters
·
13 May

Press Release: Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day

Dow Jones
·
13 May

Sangamo Therapeutics Delays Q1 2025 Earnings Call to Later Time on May 12

Reuters
·
13 May

Sangamo Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
10 May

Press Release: Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

Dow Jones
·
07 May

Sangamo Therapeutics: St-920 Study Pivotal Data Readout Expected by End of Q2 2025

THOMSON REUTERS
·
06 May

Sangamo Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
05 May

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Business Wire
·
29 Apr

US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

Benzinga
·
04 Apr

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday

Benzinga
·
04 Apr

Stocks to Watch: Pamt, CXApp, Sangamo Therapeutics

Dow Jones
·
04 Apr

BRIEF-Sangamo Therapeutics Announces Capsid License Agreement With Lilly To Deliver Genomic Medicines For Diseases Of The Central Nervous System

Reuters
·
04 Apr